For: |
Ye JX, Liu Y, Qin Y, Zhong HH, Yi WN, Shi XY. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i5/1595.htm |
Number | Citing Articles |
1 |
Hai Luo, Lingzhi Cui, Kexin Shen, Ruiqi Li, Zeming Wang, Zhongshi Xie. HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer. Cancer Management and Research 2021; : 3443 doi: 10.2147/CMAR.S297596
|
2 |
Susanti Susanti, Satrio Wibowo, Gilang Akbariani, Naomi Yoshuantari, Didik Setyo Heriyanto, Asep Muhamad Ridwanuloh, Hariyatun Hariyatun, Adeodatus Yuda Handaya, Johan Kurnianda, Susanna Hilda Hutajulu, Mohammad Ilyas. Molecular Analysis of Colorectal Cancers Suggests a High Frequency of Lynch Syndrome in Indonesia. Cancers 2021; 13(24): 6245 doi: 10.3390/cancers13246245
|
3 |
Mabel Elena Bohórquez L, Ángel Alexandro Criollo R, Luis Carvajal Carmona, María Magdalena Echeverry de Polanco. Cáncer de colon en Colombia, fenotipo molecular: tamizaje para síndromes con agregación familiar. Revista de la Asociación Colombiana de Ciencias Biológicas 2019; : 87 doi: 10.47499/revistaaccb.v1i31.185
|
4 |
Francisco Sir-Mendoza, Farith González-Martínez, Meisser Madera . Prevalence of KRAS, PIK3CA, BRAF and AXIN2 gene mutations in colorectal cancer and its relationship with dental agenesis: a systematic review. Revista de la Facultad de Medicina 2021; 71(1): e95595 doi: 10.15446/revfacmed.v71n1.95595
|
5 |
Xiao-na Chang, Fu-mei Shang, Hong-yu Jiang, Chen Chen, Zhe-yan Zhao, Sheng-he Deng, Jun Fan, Xiao-chuan Dong, Ming Yang, Yan Li, Kai-lin Cai, Li Liu, Hong-li Liu, Xiu Nie. Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China. Current Medical Science 2021; 41(1): 118 doi: 10.1007/s11596-021-2326-1
|
6 |
Dongdong Huang, Wenjie Sun, Yuwei Zhou, Peiwei Li, Fang Chen, Hanwen Chen, Dajing Xia, Enping Xu, Maode Lai, Yihua Wu, Honghe Zhang. Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer and Metastasis Reviews 2018; 37(1): 173 doi: 10.1007/s10555-017-9726-5
|
7 |
Jing Hu, Wen-Yue Yan, Li Xie, Lei Cheng, Mi Yang, Li Li, Jiong Shi, Bao-Rui Liu, Xiao-Ping Qian. Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer. Medicine 2016; 95(50): e5649 doi: 10.1097/MD.0000000000005649
|
8 |
Binyi Xiao, Jun Luo, E. Xie, Lingheng Kong, Jinghua Tang, Dingxin Liu, Linlin Mao, Qiaoqi Sui, Weirong Li, Zhigang Hong, Zhizhong Pan, Wu Jiang, Pei-Rong Ding. Comparisons of screening strategies for identifying Lynch syndrome among patients with MLH1-deficient colorectal cancer. European Journal of Human Genetics 2020; 28(11): 1555 doi: 10.1038/s41431-020-0687-8
|
9 |
Jinlong Jiao, Dandan Zeng, Yafang Wu, Chentao Li, Tianlu Mo. Programmable and ultra-efficient Argonaute protein-mediated nucleic acid tests: A review. International Journal of Biological Macromolecules 2024; 278: 134755 doi: 10.1016/j.ijbiomac.2024.134755
|
10 |
Ming-zhi Xie, Ji-lin Li, Zheng-min Cai, Ke-zhi Li, Bang-li Hu. Impact of primary colorectal Cancer location on the KRAS status and its prognostic value. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0965-5
|
11 |
Lei Sheng, Jinyuan Shi, Bo Han, Bin Lv, Luchuan Li, Bo Chen, Nan Liu, Yingting Cao, Andrew G. Turner, Qingdong Zeng. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma. The American Journal of Surgery 2020; 220(2): 334 doi: 10.1016/j.amjsurg.2019.11.032
|
12 |
Berna C. Özdemir, Gian-Paolo Dotto. Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?. Trends in Cancer 2017; 3(3): 181 doi: 10.1016/j.trecan.2017.02.002
|
13 |
Somayeh Igder, Javad Mohammadiasl, Pooneh Mokarram. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions. Biochemical Genetics 2019; 57(6): 767 doi: 10.1007/s10528-019-09918-0
|
14 |
Weicheng Wang, Rui Wang, Xiao Han, Wei Zhang, Lijun Zhu, Yanhong Gu. Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I–III colorectal cancer. Medicine 2024; 103(14): e37693 doi: 10.1097/MD.0000000000037693
|
15 |
Srujana Joga, Sumit Goyal, Anurag Mehta, Manish Sharma, Venkata Pradeep Babu Koyyala, Pankaj Goyal, Chaturbhuj Aggarwal, M. Shiv Shankara Swamy, Amrith B Patel, Shrinidhi Nathany, Moushumi Suryavanshi, Anurag Sharma, Satya Narayan Saraswat, Satyajeet Soni, Arpit Jain, Pallavi Redhu, Vineet Talwar, D C Doval. A Study of Molecular Subtypes (Profile) of Colorectal Cancer and Their Correlation with Clinical and Pathological Profile in a Tertiary Care Center in India. South Asian Journal of Cancer 2025; doi: 10.1055/s-0044-1801346
|
16 |
Yongle Chen, Zexian Chen, Juanni Huang, Jiancong Hu, Xiaowen He, Ping Lan, Xiaosheng He. Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location. International Journal of Clinical Oncology 2022; 27(4): 749 doi: 10.1007/s10147-021-02101-9
|
17 |
Wenbo Niu, Guiying Wang, Jun Feng, Zheng Li, Chenhui Li, Baoen Shan. Correlation between microsatellite instability and RAS gene mutation and stage Ⅲ colorectal cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.9611
|
18 |
Somayeh Igder, Javad Mohammadiasl, Shima Azadpour, Esrafil Mansouri, Hassan Ashktorab, Pooneh Mokarram. KRAS mutation and abnormal expression of Cripto‐1 as two potential candidate biomarkers for detection of colorectal cancer development. Journal of Cellular Biochemistry 2020; 121(4): 2901 doi: 10.1002/jcb.29526
|
19 |
Xiaoli Jia, Bin Li, Hui Wang, Zhe Yan. Clinical Features, Molecular Alterations and Prognosis of Colorectal Adenocarcinoma With Mucinous Component in Chinese Patients. Applied Immunohistochemistry & Molecular Morphology 2021; 29(10): 765 doi: 10.1097/PAI.0000000000000950
|
20 |
Jiang Liu, Li Tang, Jinhua Yi, Guimei Li, Youwang Lu, Yu Xu, Shuhua Zhao, Rui Mao, Xiaolu Li, Li Ren, Kunhua Wang. Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1086-x
|
21 |
Weihua Li, Tian Qiu, Lei Guo, Jianming Ying, Aiping Zhou. NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction. Pathology - Research and Practice 2019; 215(3): 483 doi: 10.1016/j.prp.2018.12.037
|
22 |
Aghigh koochak, Nasser Rakhshani, Mohammad Hadi Karbalaie Niya, Fahimeh Safarnezhad Tameshkel, Masoud Reza Sohrabi, Mohammad Reza Babaee, Hamid Rezvani, Babak Bahar, Farid Imanzade, Farhad Zamani, Mohammad Reza Khonsari, Hossein Ajdarkosh, Gholamreza Hemmasi. Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran. Asian Pacific Journal of Cancer Prevention 2016; 17(2): 603 doi: 10.7314/APJCP.2016.17.2.603
|
23 |
Xiangyan Zhang, Jie Wu, Lili Wang, Han Zhao, Hong Li, Yuhe Duan, Yujun Li, Ping Xu, Wenwen Ran, Xiaoming Xing. HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China. PeerJ 2020; 8: e8602 doi: 10.7717/peerj.8602
|
24 |
Dan Jiang, Chang Shu, Weihan Zhang, Linyong Sun, Mengni Zhang, Yanjun He, Gemma Owen, Wanjun Jin, Du He, Xiangbing Deng, Xiaoyu Liu. Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy. Virchows Archiv 2021; 478(2): 231 doi: 10.1007/s00428-020-02878-6
|
25 |
Daeyoun David Won, Jae Im Lee, In Kyu Lee, Seong-Taek Oh, Eun Sun Jung, Sung Hak Lee. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3381-7
|
26 |
Xizhen Sun, Dongyan Zhao, Sidan Long, Shuo Chen, Qian Cai, Shukun Yao. Clinicopathological and molecular features of colorectal cancer with synchronous adenoma. Scandinavian Journal of Gastroenterology 2020; 55(9): 1063 doi: 10.1080/00365521.2020.1795922
|
27 |
Xiaoli Tan, Yongzhen Fang, Xinjuan Fan, Weihao Deng, Jinglin Huang, Yacheng Cai, Jiaxin Zou, Zhiting Chen, Hanjie Lin, Liang Xu, Guannan Wang, Huanmiao Zhan, Shuhui Huang, Xinhui Fu. Testing region selection and prognostic analysis of MLH1 promoter methylation in colorectal cancer in China. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goae011
|
28 |
Xiangyan Zhang, Wenwen Ran, Jie Wu, Hong Li, Huamin Liu, Lili Wang, Yujing Xiao, Xiaonan Wang, Yujun Li, Xiaoming Xing. Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China. PeerJ 2018; 6: e4341 doi: 10.7717/peerj.4341
|
29 |
Xinhui Fu, Yan Huang, Xinjuan Fan, Yanhong Deng, Huanliang Liu, Hongzhi Zou, Peihuang Wu, Zhiting Chen, Jinglin Huang, Jingxuan Wang, Hanjie Lin, Shuhui Huang, Xiaoli Tan, Ping Lan, Lei Wang, Jian‐ping Wang. Demographic trends and KRAS/BRAFV600E mutations in colorectal cancer patients of South China: A single‐site report. International Journal of Cancer 2019; 144(9): 2109 doi: 10.1002/ijc.31973
|
30 |
Yajian Wang, Haijing Liu, Yingyong Hou, Xiaoyan Zhou, Li Liang, Zhihong Zhang, Huaiyin Shi, Sanpeng Xu, Peizhen Hu, Zuyu Zheng, Rui Liu, Tingdong Tang, Feng Ye, Zhiyong Liang, Hong Bu. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients. Virchows Archiv 2018; 472(6): 959 doi: 10.1007/s00428-018-2359-4
|
31 |
Wenmiao Wang, Jianming Ying, Susheng Shi, Qiurong Ye, Shuangmei Zou, Lin Dong, Ning Lyu. A modified screening strategy for Lynch syndrome among MLH1-deficient CRCs: Analysis from consecutive Chinese patients in a single center. Translational Oncology 2021; 14(5): 101049 doi: 10.1016/j.tranon.2021.101049
|
32 |
Yun Wang, Lu-Yao Ma, Xiao-Ping Yin, Bu-Lang Gao. Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.689509
|
33 |
Junjie Peng, Dan Huang, Graeme Poston, Xiaoji Ma, Renjie Wang, Weiqi Sheng, Xiaoyan Zhou, Xiaoli Zhu, Sanjun Cai. The molecular heterogeneity of sporadic colorectal cancer with different tumor sites in Chinese patients. Oncotarget 2017; 8(30): 49076 doi: 10.18632/oncotarget.16176
|
34 |
Tony Ibrahim, Claude Saer-Ghorra, Vivane Trak-Smayra, Samah Nadiri, Charbel Yazbeck, Maria Baz, Joseph G. Kattan. Molecular characteristics of colorectal cancer in a Middle Eastern population in a single institution. Annals of Saudi Medicine 2018; 38(4): 251 doi: 10.5144/0256-4947.2018.251
|
35 |
Wei-Jian Mei, Mi Mi, Jing Qian, Nan Xiao, Ying Yuan, Pei-Rong Ding. Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1019582
|
36 |
Min Jin, Jingjing Wu, Linli Shi, Bin Zhou, Fumei Shang, Xiaona Chang, Xiaochuan Dong, Shenghe Deng, Li Liu, Kailin Cai, Xiu Nie, Tao Zhang, Jun Fan, Hongli Liu. Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.993285
|
37 |
Desislava Tashkova, Nevena Ilieva, Denitsa Serteva, Yana Feodorova, Nikolay Mehterov, Angelina Mollova, Svitlana Bachurska. Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status. Folia Medica 2023; 65(3): 378 doi: 10.3897/folmed.65.e81334
|
38 |
Fatima El agy, Sanae el Bardai, Ihsane El Otmani, Zineb Benbrahim, Ibn Majdoub Hassani Karim, Khalid Mazaz, El Bachir Benjelloun, Abdelmalek Ousadden, Mohammed El Abkari, Sidi Adil Ibrahimi, Laila Chbani, Hassan Ashktorab. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report. PLOS ONE 2021; 16(3): e0248522 doi: 10.1371/journal.pone.0248522
|